Hepatic microbodies were first described in 1956 by Rouiller and Bernhard (1) and by Gansler and Rouiller (2) . In the rat, they are round or oval bodies that are somewhat smaller than mitochondria. They are delimited by a unit membrane and possess a moderately dense matrix and a dense core or nucleoid with a distinctive crystalloid arrangement.
Microbodies have been characterized biochemically in rat liver and kidney by de Duve and his colleagues (3, 4) . Density gradient centrifugation of rat liver has yielded fractions with numerous microbodies and high levels of urate oxidase (uricase), D-amino acid oxidase, and L-a-hydroxy acid oxidase, oxidases that form hydrogen peroxide, and catalase, an enzyme that destroys hydrogen peroxide. Because hydrogen peroxide is either the product or substrate of these enzymes, the term "peroxisome" has recently been proposed for these particles (5) .
A preparation with an 80-fold purification of urate oxidase contains a great number of free crystalloid cores (4). These observations suggest that D-amino acid oxidase and catalase are present in the matrix and that urate oxidase is present in the core. Rat kidney microbodies have no detectable urate oxidase activity (3) . It is of interest that in published electron micrographs, as in our own studies, rat kidney microbodies have central densities but no crystalloid structures (see Fig. 10 in reference 6).
Although fish, amphibia, and most mammals exhibit urate oxidase activity, primates (including man), birds, and most reptiles lack this enzyme. The absence of urate oxidase in human and chick liver is consistent with the absence of the nucleoid in specimens examined in the electron microscope (7) .
This report describes the presence of crystalloidcontaining microbodies in a biopsy specimen of human liver.
MATERIALS AND METHODS
Human liver biopsy specimens were obtained in two instances from a 27-year-old white seaman with Pathology and the Department of Medicine, Albert Bronx, New York idiopathic recurrent cholestatic jaundice (8), diabetes mellitus, and thalassemia minor. The first specimen was obtained at surgery when the patient was jaundiced. The second biopsy, a Menghini needle specimen, was taken during remission. The tissue was fixed in cold 1%, phosphate-buffered osmium tetroxide (9) for 3 hr and embedded in Epon (I0). Thin sections were cut with a diamond knife on an LKB microtome and stained with lead citrate (11) (sometimes after staining with dilute alcoholic uranyl acetate (12) ) and examined in a Siemens Elmiskop I at 80 kv.
OBSERVATIONS AND DISCUSSION
In the first biopsy specimen, the parenchymal cells were strikingly abnormal. Bile canaliculi were dilated and their microvilli were distended and reduced in number. Bile pigment was often found in the cytoplasm; glycogen was markedly increased in amount and lipid spheres were numerous. The microbodies resembled those previously described in human liver (7), displaying a homogeneous matrix without evident nucleoids. They were seen throughout the cytoplasm, without appreciable concentration along the bile canaliculi. The second biopsy specimen, taken while the patient was anicteric, showed relatively moderate alterations such as deposits of glycogen within nuclei ( Figs. 1 and 2 ) and the presence of occasional intracytoplasmic bile. Within the cytoplasm of the hepatocytes was a large number of round or irregularly oval microbodies, measuring 0.4 to 1.0 /~, delimited by unit membranes. They possessed a homogeneous matrix with a dense central crystalloid core, and were remarkably similar to microbodies described in hepatocytes of the rat and other species. These nucleoid-containing microbodies were present in the thin sections cut from all six embedded pieces of tissue.
Transverse section shows the dense crystalloid to be composed of regular arrays of two tubulelike structures. The larger of these "tubules" has a diameter of about 200 A, and it is surrounded by ten smaller "tubules," approximately 50 A in diameter, constituting a structure similar to that for microbody crystalloids of the rat liver as sug-FIGURE 1 Electron micrograph of liver from the second biopsy, stained with lead citrate (ll). Arrows indicate numerous microbodies, most of them containing dense nucleoids. The cytoplasm is otherwise not remarkable. Mitochondria are seen at M, endoplasmic reticulum at ER, lipid droplets at L, bile canalicnli at Bc, and collagen at C. Marked glycogen deposits (G) are seen in the nucleus (N) of the hepatoeyte (~9. × 10,000. FIGURE 2 Enlargement of a portion of the nucleus of the altered parenchymal cell shown in Fig. 1 . Note the monoparticulate form of glycogen that has been reported in numerous human diseases (16) (17) (18) .
X 48,000. I~IOITRE 3 A portion of another hepatocyte from the same biopsy, stained with lead citrate (11). Three microbodies are sectioned at different levels. In Mb 1, the crystalloid is sectioned essentially transversally. The "tubules" are seen in longitudinal section in Mb 2; this microbody also shows the delimiting membrane (arrow). In Mb 3, a portion of the nucleoid is seen in diagonal section. )< 52,500.
gested by Hruban and Swift (13) (Fig. 3) . The parallel arrangement of the "tubules" is evident in longitudinal sections.
The finding of a nucleoid structure in human liver microbodies raises questions that cannot be answered at the present time. In rat liver, the nucleoid is apparently associated with urate oxidase (14, 15) ; however, there is no definitive evidence that the crystalloid represents the enzyme (see the comments of Baudhuin et al. (4) on the earlier report of Hruban and Swift (13)). It is possible that nucleoids may exist without urate oxidase activity. Speculation concerning any relationship between the appearance of crystalloids in hepatic microbodies and remission of clinical symptoms is difficult. The patient studied has other serious metabolic disorders, including diabetes; unfortunately, other biopsies from this patient that would permit determination of urate oxidase and other activities are now unobtainable.
